Morgan Stanley’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.6M Buy
4,580,427
+84,096
+2% +$828K ﹤0.01% 2270
2025
Q4
$31.4M Sell
4,496,331
-1,372,573
-23% -$8.63M ﹤0.01% 2526
2025
Q3
$33.5M Sell
5,868,904
-347,937
-6% -$1.86M ﹤0.01% 2381
2025
Q2
$29.7M Buy
6,216,841
+2,856,846
+85% +$16.4M ﹤0.01% 2419
2025
Q1
$29.1M Sell
3,359,995
-994,054
-23% -$10.4M ﹤0.01% 2311
2024
Q4
$52.9M Sell
4,354,049
-368,713
-8% -$5.16M ﹤0.01% 1789
2024
Q3
$79.4M Sell
4,722,762
-759,185
-14% -$12.5M 0.01% 1417
2024
Q2
$85.7M Sell
5,481,947
-1,277,800
-19% -$17.8M 0.01% 1291
2024
Q1
$107M Sell
6,759,747
-5,088,037
-43% -$85.2M 0.01% 1144
2023
Q4
$238M Buy
11,847,784
+6,136,032
+107% +$104M 0.01% 1044
2023
Q3
$106M Sell
5,711,752
-447,881
-7% -$9.75M 0.01% 1018
2023
Q2
$134M Buy
6,159,633
+382,201
+7% +$6.91M 0.01% 917
2023
Q1
$107M Buy
5,777,432
+1,041,178
+22% +$19.6M 0.01% 1020
2022
Q4
$72.1M Buy
4,736,254
+2,909,393
+159% +$41.4M 0.01% 1231
2022
Q3
$25.5M Buy
1,826,861
+1,299,590
+246% +$26.2M ﹤0.01% 1937
2022
Q2
$12.7M Buy
527,271
+408,239
+343% +$11M ﹤0.01% 2815
2022
Q1
$3.67M Sell
119,032
-241,312
-67% -$8.68M ﹤0.01% 4009
2021
Q4
$16.4M Buy
360,344
+22,152
+7% +$948K ﹤0.01% 2377
2021
Q3
$14.7M Sell
338,192
-191,642
-36% -$8.34M ﹤0.01% 2437
2021
Q2
$24.4M Buy
529,834
+314,734
+146% +$14.5M ﹤0.01% 1945
2021
Q1
$9.56M Buy
215,100
+17,148
+9% +$719K ﹤0.01% 2704
2020
Q4
$7.85M Sell
197,952
-346,160
-64% -$12.9M ﹤0.01% 2771
2020
Q3
$21.3M Buy
544,112
+203,900
+60% +$7.8M ﹤0.01% 1436
2020
Q2
$13.2M Sell
340,212
-10,054
-3% -$340K ﹤0.01% 1727
2020
Q1
$11.7M Sell
350,266
-205,360
-37% -$6.74M ﹤0.01% 1659
2019
Q4
$18.1M Buy
555,626
+138,552
+33% +$4.56M ﹤0.01% 1752
2019
Q3
$14.2M Sell
417,074
-107,152
-20% -$3.71M ﹤0.01% 1784
2019
Q2
$16.3M Buy
524,226
+401,336
+327% +$11.8M ﹤0.01% 1661
2019
Q1
$3.53M Sell
122,890
-251,124
-67% -$7.59M ﹤0.01% 3051
2018
Q4
$10.7M Sell
374,014
-44,644
-11% -$1.4M ﹤0.01% 2056
2018
Q3
$15M Buy
418,658
+88,262
+27% +$3.76M ﹤0.01% 1966
2018
Q2
$13.2M Sell
330,396
-35,012
-10% -$1.29M ﹤0.01% 2063
2018
Q1
$12.2M Sell
365,408
-108,936
-23% -$3.28M ﹤0.01% 2152
2017
Q4
$14.6M Buy
474,344
+82,251
+21% +$2.49M ﹤0.01% 1991
2017
Q3
$11.4M Sell
392,093
-15,584
-4% -$401K ﹤0.01% 2156
2017
Q2
$10.6M Buy
407,677
+23,477
+6% +$562K ﹤0.01% 2133
2017
Q1
$9.44M Sell
384,200
-131,728
-26% -$3.22M ﹤0.01% 2253
2016
Q4
$12.8M Buy
515,928
+198,901
+63% +$4.42M ﹤0.01% 1996
2016
Q3
$6.65M Buy
317,027
+51,683
+19% +$1.11M ﹤0.01% 2400
2016
Q2
$5.6M Buy
265,344
+9,859
+4% +$184K ﹤0.01% 2509
2016
Q1
$4.82M Sell
255,485
-5,918
-2% -$113K ﹤0.01% 2566
2015
Q4
$5.54M Sell
261,403
-149,829
-36% -$3.06M ﹤0.01% 2567
2015
Q3
$6.94M Buy
411,232
+191,403
+87% +$3.77M ﹤0.01% 2341
2015
Q2
$3.91M Sell
219,829
-347,704
-61% -$6.02M ﹤0.01% 3008
2015
Q1
$9.95M Buy
567,533
+259,797
+84% +$4.76M ﹤0.01% 2065
2014
Q4
$5.72M Sell
307,736
-124,048
-29% -$2.04M ﹤0.01% 2599
2014
Q3
$6.39M Sell
431,784
-480
-0.1% -$7.58K ﹤0.01% 2424
2014
Q2
$6.56M Sell
432,264
-60,405
-12% -$897K ﹤0.01% 2418
2014
Q1
$8.3M Buy
492,669
+7,717
+2% +$126K ﹤0.01% 2106
2013
Q4
$8.31M Buy
484,952
+206,792
+74% +$3.6M ﹤0.01% 2098
2013
Q3
$4.22M Buy
278,160
+23,820
+9% +$341K ﹤0.01% 2597
2013
Q2
$3.53M Buy
+254,340
New +$3.36M ﹤0.01% 2652

Other funds holding NEOG

Morgan Stanley's NEOG Position: Q1 2026 in Review

Morgan Stanley increased its Neogen (NEOG) stake by 1.9% in Q1 2026, buying an estimated $828K and bringing the position to 4,580,427 shares worth $42.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Morgan Stanley first reported a position in NEOG in Q2 2013 and has held it in 52 quarters since. The position peaked at $238M in Q4 2023. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Morgan Stanley held 4,580,427 shares of Neogen worth $42.6M as of Q1 2026.
  • Morgan Stanley bought 84,096 Neogen shares in Q1 2026, an estimated $828K.
  • Neogen made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2270 holding.
  • Morgan Stanley first reported a position in Neogen in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Neogen position peaked at $238M in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.